Guggenheim Issues Positive Forecast for Apogee Therapeutics (NASDAQ:APGE) Stock Price
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) had its price objective increased by stock analysts at Guggenheim from $95.00 to $110.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s target price would indicate a potential upside of 150.23% from the stock’s current price. A number […]
More Stories
US Mortgage Rates Fall for First Time in 6 Weeks
By Naveen Athrappully The weekly average rate on a 30-year fixed-rate mortgage declined for the most recent week, breaking a...
What Battleground Voters Are Saying About Healthcare Affordability
By Lawrence Wilson “Yes, I do have opinions about this,” said Milwaukee resident Addaru Valentine just after voting in Wisconsin’s...
UAE Accuses Iran of Attacking Abu Dhabi National Oil Company Vessel in Strait of Hormuz
By Jacki Thrapp The United Arab Emirates (UAE) accused the Iranian regime of attacking an Abu Dhabi National Oil Company...
Federal Judge Declines to Block Border Wall Construction on Arizona Tribal Land
By Aldgra Fredly A federal judge on Aug. 14 refused to block the Trump administration from building a border wall...
Wall Street Review: S&P 500 Hits Record High as Inflation Cools, Earnings Stay Strong
By Panos Mourdoukoutas The S&P 500 climbed to a fresh record high this week, powered by new data showing inflation...
Fauci Refuses to Appear Before 2nd Senate Panel After Contempt Vote
By Tom Ozimek Dr. Anthony Fauci has declined a request to appear voluntarily before a second Senate panel, days after...